More than one in six men will develop prostate cancer in their lifetime. In recent years there has been an explosion of information regarding PSA screening and biomarkers for the disease. In Prostate Cancer Screening, Second Edition, the world’s leading experts on prostate cancer detection update the first edition with the latest findings. The book incorporates a series of thoughtful and cutting-edge works from the world’s experts in prostate cancer screening, ranging from the current status quo of prostate cancer screening across the globe to consensus on optimal utilization of the traditional PSA and DRE tests, to cutting-edge research in new biomarkers, biomeasures, and extended risk algorithms for prostate cancer. An additional chapter covers family-based linkage analysis as well as possible pitfalls in prostate cancer biomarker evaluation studies. Timely and authoritative, Prostate Cancer Screening, Second Edition, is an essential text for urologists, oncologists and family physicians, as well as researchers in the biomarker industry who seek methods to better develop and support markers and measures of prostate cancer.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
More than one in six men will develop prostate cancer in their lifetime. In recent years there has been an explosion of information regarding PSA screening and biomarkers for the disease. In Prostate Cancer Screening, Second Edition, the world’s leading experts on prostate cancer detection update the first edition with the latest findings. The book incorporates a series of thoughtful and cutting-edge works from the world’s experts in prostate cancer screening, ranging from the current status quo of prostate cancer screening across the globe to consensus on optimal utilization of the traditional PSA and DRE tests, to cutting-edge research in new biomarkers, biomeasures, and extended risk algorithms for prostate cancer. An additional chapter covers family-based linkage analysis as well as possible pitfalls in prostate cancer biomarker evaluation studies. Timely and authoritative, Prostate Cancer Screening, Second Edition, is an essential text for urologists, oncologists and family physicians, as well as researchers in the biomarker industry who seek methods to better develop and support markers and measures of prostate cancer.
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Anbieter: Devils in the Detail Ltd, Oxford, Vereinigtes Königreich
Zustand: Very Good. Picture Shown is For Illustration Purposes Only, Please See Below For Further DetailsCONDITION ? VERY GOOD - PAPERBACKlight wear and scuff marks to cover, light grub to fore edges, pages in nice condition, shipped from the UK. Artikel-Nr. 125/BLR/665P 8539
Anzahl: 1 verfügbar
Anbieter: preigu, Osnabrück, Deutschland
Taschenbuch. Zustand: Neu. Prostate Cancer Screening | Second Edition | Donna Pauler Ankerst (u. a.) | Taschenbuch | xvi | Englisch | 2014 | Humana Press | EAN 9781627038539 | Verantwortliche Person für die EU: Humana Press in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu. Artikel-Nr. 104986914
Anzahl: 5 verfügbar
Anbieter: Kennys Bookstore, Olney, MD, USA
Zustand: New. In this second edition, the world's leading experts on prostate cancer detection update the previous edition with the latest findings. It incorporates a series of thoughtful and cutting-edge works from the world's experts in prostate cancer screening. Editor(s): Ankerst, Donna; Tangen, Catherine M.; Thompson, Ian M. Series: Current Clinical Urology. Num Pages: 397 pages, 51 black & white tables, biography. BIC Classification: MBG; MBNS; MJCL; MJS. Category: (G) General (US: Trade). Dimension: 158 x 235 x 26. Weight in Grams: 644. . 2014. 2nd ed. 2009. Paperback. . . . . Books ship from the US and Ireland. Artikel-Nr. V9781627038539
Anzahl: 15 verfügbar